CD34 and acute myeloid leukemia: LSCs are functionally defined by their ability to initiate AML in immunodeficient mice [5], and were initially identified as a population of leukemic cells with a CD34+CD38− immunophenotype, similar to normal hematopoietic stem cells (HSCs) [4,5].